Coverage

JPM: Sanofi pays $125M to take lead in new checkpoint inhibitor space

fiercebiotech / Jan 12, 2021

Biond Biologics sells cancer drug rights to Sanofi for $125m

globes / Jan 12, 2021

Biond Biologics And Sanofi Enter Into Global Licensing Agreement $125 Million Upfront And Over $1 Billion In Milestone And Royalty Payments

goodwin / Jan 12, 2021

Sanofi Keeps on Rolling With Biond Biologics Partnership

biospace / Jan 12, 2021